Gsa Capital Partners LLP Prime Medicine, Inc. Transaction History

Gsa Capital Partners LLP

  • $1.11 Billion
  • Q1 2025

A detailed history of Gsa Capital Partners LLP transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Gsa Capital Partners LLP holds 153,273 shares of PRME stock, worth $370,920. This represents 0.03% of its overall portfolio holdings.

Number of Shares
153,273
Previous 15,311 901.06%
Holding current value
$370,920
Previous $45,000 577.78%
% of portfolio
0.03%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 08, 2025
BUY
$1.72 - $3.35 $237,294 - $462,172
137,962 Added 901.06%
153,273 $305,000
Q4 2024

Feb 07, 2025
SELL
$2.64 - $4.46 $221,097 - $373,520
-83,749 Reduced 84.54%
15,311 $45,000
Q3 2024

Nov 05, 2024
BUY
$3.41 - $6.7 $337,794 - $663,702
99,060 New
99,060 $383,000
Q4 2023

Feb 16, 2024
BUY
$5.59 - $9.55 $68,170 - $116,462
12,195 New
12,195 $108,000

Others Institutions Holding PRME

# of Institutions
128
Shares Held
57.7M
Call Options Held
12.4K
Put Options Held
107K
View Full List

About Prime Medicine, Inc.

PRME Quotes by TradingView
  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $232M
More about PRME
Track This Portfolio

Track Gsa Capital Partners LLP Portfolio

Follow Gsa Capital Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Gsa Capital Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email